Should You Sell Palatin Technologies PTN After 636 Drop 20260519 OpenAI Launches Guaranteed Capacity Offering to Secure Compute for Enterprise Clients Blackstone and Google Partner on 5 Billion AI Infrastructure Venture Powered by TPU Chips Should You Sell Ramaco Resources METC After 336 Drop 20260519 Rupee Tumbles to AllTime Low as Dollar Demand Crude Rally Intensify Pressure Walker Dunlop WD Surges 3 Key Support and Resistance Levels in Focus Memorial Day 2025 Stock Market Bond Market Hours and Postal Service Schedule Viatris VTRS Q1 2026 Earnings Why the Beat Matters OpenAI Gains Early Lead in AI IPO Race Amid Confidential Filing Reports Nostalgia and Speculation Fuel MultiMillion Dollar Pokmon Card Boom New York Times Wordle Continues Daily Engagement Milestone With Puzzle 1799 Morning Market Roundup Microns Milestone Dicks Earnings and Paxtons Primary Victory Trump Urges Supreme Court to Halt TikTok Ban What It Means for Investors US Consumer Sentiment Sinks to Record Low in May as Iran Conflict Fuels Inflation Fears LDOS Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 24 RRC Q1 2026 Earnings EPS Surges Past Estimates by 19 Stock Slips as Market Weighs Sector Headwinds BNGO Q1 2026 Earnings Narrowing Losses Beat Estimates but Stock Declines on Uncertain Outlook Silicom Ltd SILC Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares RTX Q1 2026 Earnings EPS Surges Past Estimates Stock Gains NFL Seeks Ban on Certain Sports Prediction Contracts Including GameSpecific Bets and Injury Markets Moderna Inc MRNA Q1 2026 Earnings Narrowerthanexpected loss as cost controls offset revenue headwinds Safe Bulkers Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower Beam Global BEEM Q1 2026 Earnings WiderThanExpected Loss Sends Shares Lower HDSN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Reacts Negatively Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline ARVN Q1 2026 Earnings EPS Beats Expectations as Pipeline Advances Without Revenue DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist MTB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher